Ketamine Induced Agitation Clinical Trial
Official title:
A Comparison of Midazolam or Haloperidol Premedication Versus Placebo for Reducing Ketamine Induced Agitation After Adult Procedural Sedation in the Emergency Department
Verified date | March 2017 |
Source | Tehran University of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Ketamine is the cornerstone of procedural sedation in emergency department but ketamine induced agitation has limited its usage by many physicians. As a solution, some propose using midazolam or haloperidol before ketamine injection. In this randomized double blind clinical trial, patients who are eligible for sedation by ketamine are allocated in 3 groups. In first group, the patients will receive 0.05 mg/kg midazolam, in second group 5 mg of haloperidol and in 3rd group a placebo five minutes before receiving the sedative dose of ketamine (1 mg/kg). The patients are assessed for agitation during and after the procedure the clinician's satisfaction with sedation instrument is evaluated after the procedure.
Status | Completed |
Enrollment | 185 |
Est. completion date | July 2017 |
Est. primary completion date | April 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - adult patient older than 18, who need to sedate in Emergency Department Exclusion Criteria: - age younger than 18 years, - patients with significant cardiovascular disease,congestive heart failure (CHF) - central nervous system lesions or injuries, increased intracranial pressure (ICP) - ocular pathology, increased intraocular pressure (IOP) - thyroid disease, - acute pulmonary infections, - conditions requiring stimulation of the posterior pharynx, - had ingested solid food in the previous 4 hours or clear liquids in the previous 2 hours. - Acute intermittent porphyria - Alcoholism - Hepatic Impairment - Myasthenia gravis - Respiratory depression - allergy to haloperidol as established by direct questioning of family members and available medical history, - moderate to severe dementia as documented by medical history, - Parkinson's disease, - corrected QTc interval (QTc) greater than 500 ms, - usage of drugs prolonging QT-interval, - history of torsades de pointes, - history of neuroleptic malignant syndrome, - family history of dystonic reactions to drugs, - epilepsy or history of seizures - chronic psychiatric disease, - intoxication - bone marrow suppression - pregnancy |
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Sina Hospital | Tehran |
Lead Sponsor | Collaborator |
---|---|
Tehran University of Medical Sciences |
Iran, Islamic Republic of,
Amr MA, Shams T, Al-Wadani H. Does haloperidol prophylaxis reduce ketamine-induced emergence delirium in children? Sultan Qaboos Univ Med J. 2013 May;13(2):256-62. Epub 2013 May 9. — View Citation
Chudnofsky CR, Weber JE, Stoyanoff PJ, Colone PD, Wilkerson MD, Hallinen DL, Jaggi FM, Boczar ME, Perry MA. A combination of midazolam and ketamine for procedural sedation and analgesia in adult emergency department patients. Acad Emerg Med. 2000 Mar;7(3):228-35. — View Citation
Newton A, Fitton L. Intravenous ketamine for adult procedural sedation in the emergency department: a prospective cohort study. Emerg Med J. 2008 Aug;25(8):498-501. doi: 10.1136/emj.2007.053421. — View Citation
Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial. Ann Emerg Med. 2011 Feb;57(2):109-114.e2. doi: 10.1016/j.annemergmed.2010.09.010. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | agitation | assessed by Pittsburgh Agitation Scale(scoring 0 to 16). Pittsburgh Agitation Scale(scoring 0 to 16) is a valid and reliable instrument to assess agitation severity of inpatients. |
starts at the time of Ketamine injection through recovery period(maximum of 2 hours) | |
Primary | level of sedation | assessed by Richmond Agitation-Sedation Scale(scoring -5 to +4). Richmond Agitation-Sedation Scale(scoring -5 to +4) is a valid and reliable instrument to assess level of sedation and agitated behavior during sedation. |
5 minutes after Ketamine injection | |
Primary | level of sedation | assessed by Richmond Agitation-Sedation Scale(scoring -5 to +4). Richmond Agitation-Sedation Scale(scoring -5 to +4) is a valid and reliable instrument to assess level of sedation and agitated behavior during sedation. |
15 minutes after Ketamine injection | |
Primary | level of sedation | assessed by Richmond Agitation-Sedation Scale(scoring -5 to +4). Richmond Agitation-Sedation Scale(scoring -5 to +4) is a valid and reliable instrument to assess level of sedation and agitated behavior during sedation. |
30 minutes after Ketamine injection | |
Secondary | clinician's satisfaction | assessed by a Clinician Satisfaction with Sedation Instrument(CSSI) questionnaire | starts at the time of Ketamine injection through recovery period(maximum of 2 hours) |